A Single Group Study to Evaluate the Efficacy of a Cosmetic Product Line on Acne Symptoms

NCT06122467 | Completed

• 1 other identifier: 20365
• Study Type: interventional
• Target: 36
• Locations: 1 country
• Sites: 1

Brief Summary

This twelve-week trial will examine the effectiveness of a Menning Labs EQ Product Line acne product. Participants will use the exfoliating cleanser, cream, and gel daily for 8 weeks. Participants will complete questionnaires at Baseline, Day 1, Day 3, Day 7, Day 28, Day 42, and Day 56. Participants will also provide before-and-after photos at Baseline, Day 7, and Day 42, as well as undergo expert skin grading at Baseline and Day 42. The questionnaire on Day 56 will mark the conclusion of the trial.

Conditions

Acne

Outcome Measures

Primary Outcomes (2)

• Change in the appearance of facial skin acne. [Timeframe: Baseline to Day 56]

  Assessed via expert skin grading of baseline and endline photos conducted by a board-certified dermatologist. Study-specific surveys using a 5-point Likert scale with 5 representing the most favorable/best outcome (e.g., "Not at all") and 1 representing the least favorable/worst outcome (e.g., "Severe"). Surveys will be completed independently by study participants.

  56 days

• Changes in skin clarity i.e. reduction in acne or associated blemishes. [Timeframe: Baseline to Day 56]

  Assessed via expert skin grading of baseline and endline photos conducted by a board-certified dermatologist. Study-specific surveys using a 5-point Likert scale with 5 representing the most favorable/best outcome (e.g., "Not at all") and 1 representing the least favorable/worst outcome (e.g., "Severe"). Surveys will be completed independently by study participants.

  56 days

Secondary Outcomes (5)

• Changes in overall skin health. [Timeframe: Baseline to Day 56]

  56 days

• Changes in skin texture. [Timeframe: Baseline to Day 56]

  56 days

• Changes in facial skin irritation. [Timeframe: Baseline to Day 56]

  56 days

• Changes in skin redness. [Timeframe: Baseline to Day 56]

  56 days

• Changes in skin smoothness. [Timeframe: Baseline to Day 56]

  56 days

Study Arms (1)

Test group: EQ Product Line

EXPERIMENTAL

The following regimen should be completed in both the morning and the evening. The order of use is: Cleanser Gel Moisturizer.

Other: EQ Exfoliating Cleanser; Other: EQ Gel; Other: EQ Moisturizer

Interventions

EQ Exfoliating Cleanser OTHER

Product contains: Purified water, disodium laureth sulfosuccinate, coco betaine, decyl glucoside, Juglans regia (walnut) shells, PEG-40 hydrogenated castor oil, sodium cocoyl isethionate disodium cocoyl glutamate, ethoxydiglycol, xanthan gum, Root Blend Preservative (hexylene glycol, caprylyl glycol, Wasabia japonica (wasabi) root extract, Zingiber officinale (ginger) root extract, Allium sativum (garlic) bulb extract), Aloe barbadensis (aloe vera) leaf juice concentrate (Aloe barbadensis leaf juice, potassium sorbate, sodium benzoate, citric acid).

Test group: EQ Product Line

EQ Gel OTHER

Product contains: Purified water, witch hazel (containing 14% grain alcohol), PEG-40 hydrogenated castor oil, ethoxydiglycol, xanthan gum, Root Blend Preservative (hexylene glycol, caprylyl glycol, Wasabia japonica (wasabi) root extract, Zingiber officinale (ginger) root extract, Allium sativum (garlic) bulb extract), xanthan gum.

Test group: EQ Product Line

EQ Moisturizer OTHER

Product contains: Purified water, glycerin, dicaprylyl carbonate, cetyl alcohol, glyceryl stearate citrate, squalane, PEG-40 hydrogenated castor oil, caprylic/capric triglycerides, stearic acid, jojoba oil, phenoxyethanol SA (phenoxyethanol, caprylyl glycol, sorbic acid), ethoxydiglycol, Root Blend Preservative (hexylene glycol, caprylyl glycol, Wasabia japonica (wasabi) root extract, Zingiber officinale (ginger) root extract, Allium sativum (garlic) bulb extract), allantoin, sodium carbomer.

Test group: EQ Product Line

Eligibility Criteria

• Age: 18 Years - 45 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Be aged between 18-45.
• Anyone who has acne prone skin and a history of recurring acne.
• Has visible acne at enrollment.
• Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
• Have a digital camera or smartphone to take photos of the face.

You may not qualify if:

• Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
• Anyone currently using a prescription skin product.
• Anyone who is unwilling to stop using the current acne supplements they are taking.
• Anyone with known severe allergic reactions.
• Any women who are pregnant, breastfeeding or attempting to become pregnant.
• Anyone unwilling to follow the study protocol.
• Anyone who identifies as having sensitive skin.

Sponsors & Collaborators

• Menning Labs: lead
• Citruslabs: collaborator

Study Sites (1)

Citruslabs

Santa Monica, California, 90404, United States

Location

MeSH Terms

Conditions

Acne Vulgaris

Condition Hierarchy (Ancestors)

Acneiform Eruptions; Skin Diseases; Skin and Connective Tissue Diseases; Sebaceous Gland Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 2, 2023
• First Posted: November 8, 2023
• Study Start: October 2, 2023
• Primary Completion: December 31, 2023
• Study Completion: December 31, 2023
• Last Updated: March 20, 2024

Record last verified: 2024-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)